Why the study?
Cardiovascular and metabolic diseases are a widespread burden, and Metrnl regulates glucose and lipid metabolism and cardiovascular homeostasis.
Key points are not available for this paper at this time.
Design
Review
May support Metrnl evaluation as biomarker or target; hypothesis-generating and requires prospective trials before clinical adoption.
Modern human society is burdened with the pandemic of cardiovascular and metabolic diseases. Metrnl is a widely distributed secreted protein in the body, involved in regulating glucose and lipid metabolism and maintaining cardiovascular system homeostasis. In this review, we present the predictive and therapeutic roles of Metrnl in various cardiovascular and metabolic diseases, including atherosclerosis, ischemic heart disease, cardiac remodeling, heart failure, hypertension, chemotherapy-induced myocardial injury, diabetes mellitus, and obesity.
No takes yet. Share an insight, caveat, or question.
Dong et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: